Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
semaglutide pharmaceutical company Ajanta Pharma Ltd., a specialty formulation company, today announced that it has entered into an in-licensing agreement with Biocon Ltd. for Semaglutide, a GLP-1 receptor agonist. Under the agreement, Biocon will Color:Silver Silk 2026GLP-1 Dangerous Medication
Dangerous Medication
55,58 However, postmarketing data on exenatide indicate an increase in INR, which is sometimes associated with bleeding events, highlighting the need for close INR monitoring after GLP-1 RA treatment
2026GLP-1
Color:Silver Silk
J.B.K., D.J.E., R.B.R., D.A.P., and V.M.J
US$ 27.20
US$ 23.50
US$ 28.68
US$ 28.10
US$ 22.07
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 25.80
US$ 25.24
US$ 27.07
US$ 20.31
